Pharmacokinetics and Pharmacodynamics of Dabigatran 75 mg b.i.d. in Patients With Severe Chronic Kidney Disease

J Am Coll Cardiol. 2016 May 24;67(20):2442-2444. doi: 10.1016/j.jacc.2016.03.516.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antithrombins / administration & dosage
  • Antithrombins / pharmacokinetics
  • Antithrombins / pharmacology*
  • Dabigatran / administration & dosage
  • Dabigatran / pharmacokinetics
  • Dabigatran / pharmacology*
  • Drug Administration Schedule
  • Female
  • Humans
  • Male
  • Prospective Studies
  • Renal Insufficiency, Chronic / metabolism*
  • Severity of Illness Index

Substances

  • Antithrombins
  • Dabigatran